The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Alterations in Gastrointestinal, Endocrine, and Metabolic Processes After Bariatric Roux-en-Y Gastric Bypass Surgery
Open accessAbstract
OBJECTIVE: Obesity leads to severe long-term complications and reduced life expectancy. Roux-en-Y gastric bypass (RYGB) surgery induces excessive and continuous weight loss in (morbid) obesity, although it causes several abnormal anatomical and physiological conditions. RESEARCH DESIGN AND METHODS: To distinctively unveil effects of RYGB surgery on β-cell function and glucose turnover in skeletal muscle, liver, and gut, nondiabetic, morbidly obese patients were studied before (pre-OP, five female/one male, BMI: 49 ± 3 kg/m2, 43 ± 2 years of age) and 7 ± 1 months after (post-OP, BMI: 37 ± 3 kg/m2) RYGB surgery, compared with matching obese (CONob, five female/one male, BMI: 34 ± 1 kg/m2, 48 ± 3 years of age) and lean controls (CONlean, five female/one male, BMI: 22 ± 0 kg/m2, 42 ± 2 years of age). Oral glucose tolerance tests (OGTTs), hyperinsulinemic-isoglycemic clamp tests, and mechanistic mathematical modeling allowed determination of whole-body insulin sensitivity (M/I), OGTT and clamp test β-cell function, and gastrointestinal glucose absorption. RESULTS: Post-OP lost (P < 0.0001) 35 ± 3 kg body weight. M/I increased after RYGB, becoming comparable to CONob, but remaining markedly lower than CONlean (P < 0.05). M/I tightly correlated (τ = −0.611, P < 0.0001) with fat mass. During OGTT, post-OP showed ≥15% reduced plasma glucose from 120 to 180 min (≤4.5 mmol/L), and 29-fold elevated active glucagon-like peptide-1 (GLP-1) dynamic areas under the curve, which tightly correlated (r = 0.837, P < 0.001) with 84% increased β-cell secretion. Insulinogenic index (0–30 min) in post-OP was ≥29% greater (P < 0.04). At fasting, post-OP showed approximately halved insulin secretion (P < 0.05 vs. pre-OP). Insulin-stimulated insulin secretion in post-OP was 52% higher than before surgery, but 1–2 pmol/min2 lower than in CONob/CONlean (P < 0.05). Gastrointestinal glucose absorption was comparable in pre-OP and post-OP, but 9–26% lower from 40 to 90 min in post-OP than in CONob/CONlean (P < 0.04). CONCLUSIONS: RYGB surgery leads to decreased plasma glucose concentrations in the third OGTT hour and exaggerated β-cell function, for which increased GLP-1 release seems responsible, whereas gastrointestinal glucose absorption remains unchanged but lower than in matching controls.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Bariatric surgery leads to loss of fat mass394, alters gut hormones395 and can exacerbate weight loss-induced sarcopenia396–398 and osteoporosis399–402.”
From Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies (2018) · cites this paper as [395]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457
Medical Consequences of Obesity
Bray, G. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0535 · Cited by 1,538
Rubino, F., Forgione, A., Cummings, D. E., Vix, M., Gnuli, D., Mingrone, G., Castagneto, M., & Marescaux, J. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000224726.61448.1b · Cited by 928 · cited 3×
“These results seem surprising because they rather point away from a pronounced malabsorption after RYGB, but are in line with previous studies applying oral D-xylose loading tests in diabetic rats and humans (13,14).”
BackgroundResultBariatric Surgery Worldwide 2003
Buchwald, H., & Williams, S. E. (2004) · Obesity Surgery · doi:10.1381/0960892042387057 · Cited by 731
Laferrère, B., Teixeira, J., McGinty, J., Tran, H., Egger, J. R., Colarusso, A., Kovack, B., Bawa, B., Koshy, N., Lee, H., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2851 · Cited by 682 · cited 3×
“From this, it follows that increased b-cell function during OGTT appears to mostly result from higher GLP-1 concentrations, as supported by studies using the GLP-1 antagonist exendin-(9-39)-amide (32).”
BackgroundResultAbdul-Ghani, M. A., Jenkinson, C. P., Richardson, D. K., Tripathy, D., & DeFronzo, R. A. (2006) · Diabetes · doi:10.2337/db05-1200 · Cited by 500 · cited 4×
“From this, it follows that increased b-cell function during OGTT appears to mostly result from higher GLP-1 concentrations, as supported by studies using the GLP-1 antagonist exendin-(9-39)-amide (32).”
BackgroundMethodResultInfluentialMechanisms of Recovery From Type 2 Diabetes After Malabsorptive Bariatric Surgery
Guidone, C., Manco, M., Valera-Mora, E., Iaconelli, A., Gniuli, D., Mari, A., Nanni, G., Castagneto, M., Calvani, M., & Mingrone, G. (2006) · Diabetes · doi:10.2337/db06-0068 · Cited by 368
Patti, M. E., McMahon, G., Mun, E. C., Bitton, A., Holst, J. J., Goldsmith, J., Hanto, D. W., Callery, M., Arky, R., Nose, V., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-1933-x · Cited by 365 · cited 2×
“From this, it follows that increased b-cell function during OGTT appears to mostly result from higher GLP-1 concentrations, as supported by studies using the GLP-1 antagonist exendin-(9-39)-amide (32).”
BackgroundResultSalehi, M., Prigeon, R. L., & D’Alessio, D. A. (2011) · Diabetes · doi:10.2337/db11-0203 · Cited by 323
Meier, J. J., Butler, A. E., Galasso, R., & Butler, P. C. (2006) · Diabetes Care · doi:10.2337/dc06-0392 · Cited by 249 · cited 3×
“From this, it follows that increased b-cell function during OGTT appears to mostly result from higher GLP-1 concentrations, as supported by studies using the GLP-1 antagonist exendin-(9-39)-amide (32).”
Research works printed but not linked: 1
- Anderwald, 2010, Adipotoxicity revisited: shifting from metabolic to cardiometabolic risk profile, Journal of Clinical Metabolism & Diabetes, 1, 61
Cited by
Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies
Batsis, J. A., & Villareal, D. T. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0062-9 · Cited by 1,382
Bariatric and metabolic surgery: a shift in eligibility and success criteria
Frühbeck, G. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.84 · Cited by 230
Campos, G. M., Ziemelis, M., Paparodis, R., Ahmed, M., & Belt Davis, D. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2013.05.012 · Cited by 104
“[20] as an option for intractable dumping syndrome and excessive weight loss.”
BackgroundJirapinyo, P., Jin, D. X., Qazi, T., Mishra, N., & Thompson, C. C. (2017) · Obesity Surgery · doi:10.1007/s11695-017-2913-1 · Cited by 105
Contribution of Malabsorption to Weight Loss After Roux-en-Y Gastric Bypass: a Systematic Review
Mahawar, K. K., & Sharples, A. J. (2017) · Obesity Surgery · doi:10.1007/s11695-017-2762-y · Cited by 102
Metadata
- Authors
- Anderwald, C.-H., Tura, A., Promintzer-Schifferl, M., Prager, G., Stadler, M., Ludvik, B., Esterbauer, H., Bischof, M. G., Luger, A., Pacini, G., & Krebs, M.
- Affiliations
- National Research Council (IT)
- Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria
- Medical University of Vienna (AT)
- Queen Mary University of London (GB)
- Corresponding author
- Anderwald, Christian-Heinz
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2012-11-14
- Volume
- 35
- Issue
- 12
- Pages
- 2580-2587
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3507557
- OpenAlex
- W1972301694
- Cited by
- 51
- References
- 31
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 1 · 2022: 5 · 2021: 3 · 2019: 2 · 2018: 5 · 2017: 3 · 2016: 7 · 2015: 5 · 2014: 5 · 2013: 10 · 2012: 2
- FWCI
- 7.17
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Surgery › Minimally Invasive Surgical Techniques
- Keywords
- Roux-en-Y gastric bypass, morbid obesity, bariatric surgery, insulin sensitivity, beta-cell function, glucose turnover, glucagon-like peptide-1, fat mass, insulin secretion, skeletal muscle glucose uptake, hepatic glucose production, hepatic glucose uptake, postprandial blood glucose, weight loss, obesity complications
- MeSH terms
- Adult, Blood Glucose, Female, Glucose Tolerance Test, Humans, Male, Middle Aged, Gastric Bypass, Gastrointestinal Tract, Insulin-Secreting Cells, Glucagon-Like Peptide 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Alterations in Gastrointestinal, Endocrine, and Metabolic Processes After Bariatric Roux-en-Y Gastric Bypass Surgery. https://app.cochat.ai/papers/10.2337/dc12-0197
- The paper
- Anderwald, C.-H., Tura, A., Promintzer-Schifferl, M., Prager, G., Stadler, M., Ludvik, B., Esterbauer, H., Bischof, M. G., Luger, A., Pacini, G., & Krebs, M. (2012). Alterations in Gastrointestinal, Endocrine, and Metabolic Processes After Bariatric Roux-en-Y Gastric Bypass Surgery. Diabetes Care. https://doi.org/10.2337/dc12-0197
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.